Influence of BRAF mutations and RAC1b/RAC1 mRNA ratio or protein expression on outcome in patients with metastatic Colorectal Cancer (mCRC) treated with first-line chemotherapy

被引：0
|
作者：
Cuatrecasas, M. [1 ]
Alonso-Espinaco, V. [1 ]
Jares, P. [1 ]
Horndler, C. [1 ]
Castells, A. [1 ]
Lozano, J. J. [1 ]
Maurel, J. [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
VIRCHOWS ARCHIV | 2012年 / 461卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [21] Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy
    Huang, Ming-Yii
    Huang, Meng-Lin
    Chen, Ming-Jenn
    Lu, Chien-Yu
    Chen, Chin-Fan
    Tsai, Pei-Chien
    Chuang, Shih-Chang
    Hou, Ming-Feng
    Lin, Shiu-Ru
    Wang, Jaw-Yuan
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (01): : 18 - 25
  • [22] Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial)
    Stahler, A.
    Heinemann, V.
    Giessen-Jung, C.
    Crispin, A.
    Schalhorn, A.
    Stintzing, S.
    von Weikersthal, L. Fischer
    Vehling-Kaiser, U.
    Stauch, M.
    Quietzsch, D.
    Held, S.
    von Einem, J. C.
    Holch, J.
    Neumann, J.
    Kirchner, T.
    Jung, A.
    Modest, D. P.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (03) : 739 - 746
  • [23] Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study
    Baba, Hideo
    Baba, Yoshifumi
    Uemoto, Shinji
    Yoshida, Kazuhiro
    Saiura, Akio
    Watanabe, Masayuki
    Maehara, Yoshihiko
    Oki, Eiji
    Ikeda, Yasuharu
    Matsuda, Hiroyuki
    Yamamoto, Masakazu
    Shimada, Mitsuo
    Taketomi, Akinobu
    Unno, Michiaki
    Sugihara, Kenichi
    Ogata, Yutaka
    Eguchi, Susumu
    Kitano, Seigo
    Shirouzu, Kazuo
    Saiki, Yasumitsu
    Takamori, Hiroshi
    Mori, Masaki
    Hirata, Toshihiko
    Wakabayashi, Go
    Kokudo, Norihiro
    ONCOTARGET, 2015, 6 (32) : 34004 - 34013
  • [24] Influence of mRNA expression of Epiregulin (EREG) and of Amphiregulin (AREG) and RAS mutations on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial)
    Stahler, A.
    Heinemann, V
    Giessen, C.
    Crispin, A.
    Schalhorn, A.
    Stintzing, S.
    von Weikersthal, Fischer L.
    Vehling-Kaiser, U.
    Stauch, M.
    Quietzsch, D.
    Neumann, J.
    Kirchner, T.
    Jung, A.
    Modest, D. P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 81 - 81
  • [25] Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study
    Chang, Jinjia
    Lin, Guangyi
    Ye, Min
    Tong, Duo
    Zhao, Jing
    Zhu, Dan
    Yu, Qihe
    Zhang, Wen
    Li, Wenhua
    BMC CANCER, 2019, 19 (1)
  • [26] Comparative analysis of the Kohne, GERCOR and GEMCAD prognostic models in metastatic colorectal cancer (mCRC) patients treated with first-line bevacizumab-based combination chemotherapy
    Bruixola, G.
    Diaz-Beveridge, R.
    Melian, M.
    Caballero, J.
    Nino, O.
    Escoin, C.
    Akhoundova, D.
    Salvador, C.
    Segura, A.
    Gimenez, A.
    Aparicio, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S376 - S377
  • [27] Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study
    Jinjia Chang
    Guangyi Lin
    Min Ye
    Duo Tong
    Jing Zhao
    Dan Zhu
    Qihe Yu
    Wen Zhang
    Wenhua Li
    BMC Cancer, 19
  • [28] Long-term outcome of unresectable metastatic colorectal cancer (MCRC) patients (pts) treated with first-line FOLFOXIRI followed by RO surgical resection of metastases
    Masi, G.
    Bursi, S.
    Loupakis, F.
    Barbara, C.
    Brunetti, I.
    Ferraldeschi, R.
    Evangelista, W.
    Chiara, S.
    Granetto, C.
    Falcone, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 242 - 242
  • [29] Long-term outcome of unresectable metastatic colorectal cancer (MCRC) patients (PTS) treated with first-line folfoxiri followed by ro surgical resection of metastases
    Masi, G.
    Bursi, S.
    Loupakis, F.
    Barletta, M.
    Barbara, C.
    Vasile, E.
    Cupini, S.
    Brunetti, I.
    Pfanner, E.
    Di Donato, S.
    D'Auria, G.
    Fanchini, L.
    Chiara, S.
    Granetto, C.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2007, 18 : VII28 - VII28
  • [30] Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
    Izuma Nakayama
    Eiji Shinozaki
    Tomohiro Matsushima
    Takeru Wakatsuki
    Mariko Ogura
    Takashi Ichimura
    Masato Ozaka
    Daisuke Takahari
    Mitsukuni Suenaga
    Keisho Chin
    Nobuyuki Mizunuma
    Kensei Yamaguchi
    BMC Cancer, 17
12345